{
    "Trade/Device Name(s)": [
        "ePlex Blood Culture Identification Gram-Negative (BCID-GN) Panel",
        "ePlex BCID-GN Panel"
    ],
    "Submitter Information": "GenMark Diagnostics, Incorporated",
    "510(k) Number": "K213236",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182619"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PEN",
        "PAM",
        "PEO"
    ],
    "Summary Letter Date": "September 29, 2021",
    "Summary Letter Received Date": "September 30, 2021",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3365",
        "866.3980"
    ],
    "Regulation Name(s)": [
        "Multiplex Nucleic Acid Assay For Identification Of Microorganisms And Resistance Markers From Positive Blood Cultures",
        "Multiplex nucleic acid assay for identification of microorganisms and resistance markers from positive blood cultures"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology",
        "mycology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Acinetobacter baumannii",
        "Bacteroides fragilis",
        "Citrobacter",
        "Cronobacter sakazakii",
        "Enterobacter cloacae complex",
        "Enterobacter (non-cloacae complex)",
        "Escherichia coli",
        "Fusobacterium necrophorum",
        "Fusobacterium nucleatum",
        "Haemophilus influenzae",
        "Klebsiella oxytoca",
        "Klebsiella pneumoniae group",
        "Morganella morganii",
        "Neisseria meningitidis",
        "Proteus",
        "Proteus mirabilis",
        "Pseudomonas aeruginosa",
        "Salmonella",
        "Serratia",
        "Serratia marcescens",
        "Stenotrophomonas maltophilia",
        "CTX-M (blaCTX-M)",
        "IMP (blaIMP)",
        "KPC (blaKPC)",
        "NDM (blaNDM)",
        "OXA (blaOXA, OXA-23 and OXA-48 groups only)",
        "VIM (blaVIM)",
        "Pan Gram-Positive assay (Bacillus cereus group, Bacillus subtilis group, Enterococcus, Staphylococcus, Streptococcus)",
        "Pan Candida assay (Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis)"
    ],
    "Specimen Type(s)": [
        "Positive blood culture (from blood culture bottle)"
    ],
    "Specimen Container(s)": [
        "Blood culture bottle"
    ],
    "Instrument(s)/Platform(s)": [
        "GenMark ePlex Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid extraction",
        "PCR",
        "RT-PCR",
        "Competitive nucleic acid hybridization",
        "Electrochemical detection"
    ],
    "Methodologies": [
        "Multiplex PCR",
        "Nucleic acid hybridization assay",
        "Electrochemical detection",
        "Microfluidics liquid handling",
        "DNA amplification"
    ],
    "Submission Type(s)": [
        "Panel",
        "Assay",
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for ePlex Blood Culture Identification Gram-Negative (BCID-GN) Panel, a multiplex qualitative nucleic acid assay for detection and identification of gram-negative bacteria, select resistance genes, and some gram-positive and Candida species from positive blood cultures.",
    "Indications for Use Summary": "Qualitative multiplex in vitro diagnostic test for use on the ePlex Instrument to simultaneously detect and identify multiple gram-negative bacteria, antimicrobial resistance genes, certain gram-positive bacteria, and Candida species directly from positive blood culture bottles for diagnosis and management of bloodstream infections, used in conjunction with clinical assessment and other laboratory findings.",
    "fda_folder": "Microbiology"
}